EUDA Enterprise Value Over E B I T D A from 2010 to 2025
| EUDAW Stock | 0.12 0.01 9.09% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter (4.98) | Current Value (4.73) | Quarterly Volatility 188.77085571 |
Check EUDA Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EUDA Health's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 183.4 K or Interest Expense of 19.9 K, as well as many indicators such as Price To Sales Ratio of 11.37, Dividend Yield of 0.0 or Days Sales Outstanding of 25.73. EUDA financial statements analysis is a perfect complement when working with EUDA Health Valuation or Volatility modules.
EUDA | Enterprise Value Over E B I T D A |
Latest EUDA Health's Enterprise Value Over E B I T D A Growth Pattern
Below is the plot of the Enterprise Value Over E B I T D A of EUDA Health Holdings over the last few years. It is EUDA Health's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in EUDA Health's overall financial position and show how it may be relating to other accounts over time.
| Enterprise Value Over E B I T D A | 10 Years Trend |
|
Enterprise Value Over E B I T D A |
| Timeline |
EUDA Enterprise Value Over E B I T D A Regression Statistics
| Arithmetic Mean | 280.57 | |
| Geometric Mean | 107.19 | |
| Coefficient Of Variation | 67.28 | |
| Mean Deviation | 168.79 | |
| Median | 403.33 | |
| Standard Deviation | 188.77 | |
| Sample Variance | 35,634 | |
| Range | 408 | |
| R-Value | (0.81) | |
| Mean Square Error | 12,985 | |
| R-Squared | 0.66 | |
| Significance | 0.0001 | |
| Slope | (32.21) | |
| Total Sum of Squares | 534,517 |
EUDA Enterprise Value Over E B I T D A History
About EUDA Health Financial Statements
EUDA Health investors use historical fundamental indicators, such as EUDA Health's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in EUDA Health. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | (4.98) | (4.73) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for EUDA Stock Analysis
When running EUDA Health's price analysis, check to measure EUDA Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EUDA Health is operating at the current time. Most of EUDA Health's value examination focuses on studying past and present price action to predict the probability of EUDA Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EUDA Health's price. Additionally, you may evaluate how the addition of EUDA Health to your portfolios can decrease your overall portfolio volatility.